105 related articles for article (PubMed ID: 28040482)
1. Schistosoma antigens downregulate CXCL9 production by PBMC of HTLV-1-infected individuals.
Lima LM; Cardoso LS; Santos SB; Oliveira RR; Oliveira SC; Góes AM; Loukas A; Araujo MI
Acta Trop; 2017 Mar; 167():157-162. PubMed ID: 28040482
[TBL] [Abstract][Full Text] [Related]
2. Schistosoma antigens downmodulate the in vitro inflammatory response in individuals infected with human T cell lymphotropic virus type 1.
Lima LM; Santos SB; Oliveira RR; Cardoso LS; Oliveira SC; Góes AM; Loukas A; Carvalho EM; Araújo MI
Neuroimmunomodulation; 2013; 20(4):233-8. PubMed ID: 23752304
[TBL] [Abstract][Full Text] [Related]
3. Plasmatic proinflammatory chemokines levels are tricky markers to monitoring HTLV-1 carriers.
Chaves DG; Sales CC; de Cássia Gonçalves P; da Silva-Malta MC; Romanelli LC; Ribas JG; de Freitas Carneiro-Proietti AB; Martins ML
J Med Virol; 2016 Aug; 88(8):1438-47. PubMed ID: 26800845
[TBL] [Abstract][Full Text] [Related]
4. Levels of serum chemokines discriminate clinical myelopathy associated with human T lymphotropic virus type 1 (HTLV-1)/tropical spastic paraparesis (HAM/TSP) disease from HTLV-1 carrier state.
Guerreiro JB; Santos SB; Morgan DJ; Porto AF; Muniz AL; Ho JL; Teixeira AL; Teixeira MM; Carvalho EM
Clin Exp Immunol; 2006 Aug; 145(2):296-301. PubMed ID: 16879249
[TBL] [Abstract][Full Text] [Related]
5. Local and systemic production of proinflammatory chemokines in the pathogenesis of HAM/TSP.
Guerra M; Luna T; Souza A; Amorim C; Carvalho NB; Carvalho L; Tanajura D; Cardoso LS; Carvalho EM; Santos S
Cell Immunol; 2018 Dec; 334():70-77. PubMed ID: 30473006
[TBL] [Abstract][Full Text] [Related]
6. Mediators Go Together: High Production of CXCL9, CXCL10, IFN-γ, and TNF-α in HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis.
Neco HVPDC; Teixeira VGDS; da Trindade ACL; Magalhães PMR; de Lorena VMB; Castellano LRC; de Souza JR; Vasconcelos LR; de Moura PMMF; de Morais CNL
AIDS Res Hum Retroviruses; 2017 Nov; 33(11):1134-1139. PubMed ID: 28648091
[TBL] [Abstract][Full Text] [Related]
7. Modulation of glutathione intracellular levels alters the spontaneous proliferation of lymphocyte from HTLV-1 infected patients.
Novaes R; Freire-de-Lima CG; de Albuquerque RC; Affonso-Mitidieri OR; Espindola O; Lima MA; de Andrada Serpa MJ; Echevarria-Lima J
Immunobiology; 2013 Sep; 218(9):1166-74. PubMed ID: 23669236
[TBL] [Abstract][Full Text] [Related]
8. Programmed death-1 (PD-1)/PD-1 ligand pathway-mediated immune responses against human T-lymphotropic virus type 1 (HTLV-1) in HTLV-1-associated myelopathy/tropical spastic paraparesis and carriers with autoimmune disorders.
Kozako T; Yoshimitsu M; Akimoto M; White Y; Matsushita K; Soeda S; Shimeno H; Kubota R; Izumo S; Arima N
Hum Immunol; 2011 Nov; 72(11):1001-6. PubMed ID: 21851845
[TBL] [Abstract][Full Text] [Related]
9. Immunological signature of the different clinical stages of the HTLV-1 infection: establishing serum biomarkers for HTLV-1-associated disease morbidity.
Starling AL; Coelho-Dos-Reis JG; Peruhype-Magalhães V; Pascoal-Xavier MA; Gonçalves DU; Béla SR; Lambertucci JR; Labanca L; Souza Pereira SR; Teixeira-Carvalho A; Ribas JG; Trindade BC; Faccioli LH; Carneiro-Proietti AB; Martins-Filho OA
Biomarkers; 2015; 20(6-7):502-12. PubMed ID: 26474234
[TBL] [Abstract][Full Text] [Related]
10. Cytokine Networks Dysregulation during HTLV-1 Infection and Associated Diseases.
Futsch N; Prates G; Mahieux R; Casseb J; Dutartre H
Viruses; 2018 Dec; 10(12):. PubMed ID: 30563084
[TBL] [Abstract][Full Text] [Related]
11. Human T-lymphotropic virus 1 (HTLV-1)-associated lichenoid dermatitis induced by CD8+ T cells in HTLV-1 carrier, HTLV-1-associated myelopathy/tropical spastic paraparesis and adult T-cell leukemia/lymphoma.
Tokura Y; Ito T; Kawakami C; Sugita K; Kasuya A; Tatsuno K; Sawada Y; Nakamura M; Shimauchi T
J Dermatol; 2015 Oct; 42(10):967-74. PubMed ID: 26077665
[TBL] [Abstract][Full Text] [Related]
12. CSF CXCL10, CXCL9, and neopterin as candidate prognostic biomarkers for HTLV-1-associated myelopathy/tropical spastic paraparesis.
Sato T; Coler-Reilly A; Utsunomiya A; Araya N; Yagishita N; Ando H; Yamauchi J; Inoue E; Ueno T; Hasegawa Y; Nishioka K; Nakajima T; Jacobson S; Izumo S; Yamano Y
PLoS Negl Trop Dis; 2013; 7(10):e2479. PubMed ID: 24130912
[TBL] [Abstract][Full Text] [Related]
13. Human T cell lymphotropic virus type 1 (HTLV-1) proviral load of HTLV-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients according to new diagnostic criteria of HAM/TSP.
Grassi MF; Olavarria VN; Kruschewsky Rde A; Mascarenhas RE; Dourado I; Correia LC; de Castro-Costa CM; Galvão-Castro B
J Med Virol; 2011 Jul; 83(7):1269-74. PubMed ID: 21567429
[TBL] [Abstract][Full Text] [Related]
14. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
Gessain A; Mahieux R
Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
[TBL] [Abstract][Full Text] [Related]
15. Altered expression of CXCR3 and CCR6 and their ligands in HTLV-1 carriers and HAM/TSP patients.
Rafatpanah H; Felegari M; Azarpazhooh MR; Vakili R; Rajaei T; Hampson I; Hassanshahi G; Valizadeh N; Gerayli S; Hamid F; Zamanian S; MollaHosseini F; Rezaee SA
J Med Virol; 2017 Aug; 89(8):1461-1468. PubMed ID: 28206670
[TBL] [Abstract][Full Text] [Related]
16. HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP): the role of HTLV-I-infected Th1 cells in the pathogenesis, and therapeutic strategy.
Nakamura T
Folia Neuropathol; 2009; 47(2):182-94. PubMed ID: 19618340
[TBL] [Abstract][Full Text] [Related]
17. Anti-HTLV antibody profiling reveals an antibody signature for HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
Burbelo PD; Meoli E; Leahy HP; Graham J; Yao K; Oh U; Janik JE; Mahieux R; Kashanchi F; Iadarola MJ; Jacobson S
Retrovirology; 2008 Oct; 5():96. PubMed ID: 18937847
[TBL] [Abstract][Full Text] [Related]
18. Clinical and immunological consequences of human T cell leukemia virus type-I and Schistosoma mansoni co-infection.
Santos SB; Porto AF; Muniz AL; Jesus AR; Carvalho EM
Mem Inst Oswaldo Cruz; 2004; 99(5 Suppl 1):121-6. PubMed ID: 15486648
[TBL] [Abstract][Full Text] [Related]
19. Modulation of T cell responses in HTLV-1 carriers and in patients with myelopathy associated with HTLV-1.
Santos SB; Porto AF; Muniz AL; Luna T; Nascimento MC; Guerreiro JB; Oliveira-Filho J; Morgan DJ; Carvalho EM
Neuroimmunomodulation; 2006; 13(3):145-51. PubMed ID: 17119343
[TBL] [Abstract][Full Text] [Related]
20. Anti-Tax antibody levels in asymptomatic carriers, oligosymptomatic carriers, patients with rheumatologic disease or with HAM/TSP do not correlate with HTLV-1 proviral load.
de Souza JG; da Fonseca FG; Martins ML; Martins CP; de Carvalho LD; Coelho-dos-Reis JG; Carneiro-Proietti AB; Martins-Filho OA; Barbosa-Stancioli EF;
J Clin Virol; 2011 Jan; 50(1):13-8. PubMed ID: 20951636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
